TLN-372

· Treeline Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TLN-372, covering 2026-04-21 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: TLN-372 in Advanced KRAS Mutant Solid Tumors [Phase 1]